Cyclacel Pharmaceuticals, Inc. (CYCCP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.23M |
| Enterprise Value | -269,089 |
| P/E Ratio | -0.15 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.97 |
| Price/Book Ratio | 0.55 |
| Enterprise/Revenue | -1.22 |
| Enterprise/EBITDA | 0.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -2.04 |
| Operating Margin | -2.38 |
| Return On Assets | -0.41 |
| Return On Equity | -0.51 |
| Revenue | 747,000 |
| Revenue/Share | 0.28 |
| Gross Profit | 138,000 |
| EBITDA | -8.42M |
| Net Income | -3M |
| Diluted EPS | -6.45 |
| Total Cash | 3.34M |
| Total Cash/Share | 0.61 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.06 |
| Book Value Per Share | 1.24 |
| 52-Week Change | -25.84 |
| 52-Week High | 17 |
| 52-Week Low | 3.29 |
| Moving Average 50 Days | 4.98 |
| Moving Average 200 Days | 5.67 |
| Average Volume | 5,685 |
| Shares Outstanding | 2.24M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.03 |
| Last Split Factor | 1:15 |
| Last Split Date | July 07, 2025 |